Gene Quinn expressed a need for further clarification in the delegation process regarding Director Review, supporting the rationality of the proposed interim rules.
The USPTO's new rules stem from the Supreme Court's Arthrex ruling, aimed at addressing constitutional concerns about administrative patent judges' appointments.
The Director Review process, shaped by public feedback and new guidance from USPTO Director Kathi Vidal, signifies an ongoing evolution in PTAB operations post-Arthrex.
The USPTO is committed to refining the Director Review and PTAB decision processes through formalization, driven by feedback from the legal community and stakeholders.
Collection
[
|
...
]